Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland
Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadersh...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/9/4/177 |
| _version_ | 1797501467714650112 |
|---|---|
| author | Cairine Gormley Maureen Spargo Glenda Fleming Brendan Moore Michael Scott Rose Sharkey Anne Friel |
| author_facet | Cairine Gormley Maureen Spargo Glenda Fleming Brendan Moore Michael Scott Rose Sharkey Anne Friel |
| author_sort | Cairine Gormley |
| collection | DOAJ |
| description | Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadership, education and training, and research and development. A consultant respiratory pharmacist has recently been appointed at a large Health and Social Care Trust in Northern Ireland to provide expert care and clinical leadership for the medicines optimisation agenda with regards to respiratory care in Northern Ireland. Alongside clinical practice, leadership, and service development, emphasis will be placed on monitoring and evaluating the work of the consultant respiratory pharmacist with a view to gathering the necessary evidence to support the case for further investment in such consultant pharmacist posts in the region. This short communication article outlines some of the clinical and economic factors associated with the decisions to invest in the consultant pharmacist model of care in Northern Ireland |
| first_indexed | 2024-03-10T03:18:50Z |
| format | Article |
| id | doaj.art-d4357f4b40364b129a173742a9629b35 |
| institution | Directory Open Access Journal |
| issn | 2226-4787 |
| language | English |
| last_indexed | 2024-03-10T03:18:50Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacy |
| spelling | doaj.art-d4357f4b40364b129a173742a9629b352023-11-23T10:07:37ZengMDPI AGPharmacy2226-47872021-10-019417710.3390/pharmacy9040177Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern IrelandCairine Gormley0Maureen Spargo1Glenda Fleming2Brendan Moore3Michael Scott4Rose Sharkey5Anne Friel6Pharmacy Department, Altnagelvin Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UKMedicines Optimisation and Innovation Centre, Antrim BT41 2RL, UKMedicines Optimisation and Innovation Centre, Antrim BT41 2RL, UKPharmacy Department, Altnagelvin Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UKMedicines Optimisation and Innovation Centre, Antrim BT41 2RL, UKRespiratory Department, Altnagelvin Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UKPharmacy Department, Altnagelvin Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UKMedicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadership, education and training, and research and development. A consultant respiratory pharmacist has recently been appointed at a large Health and Social Care Trust in Northern Ireland to provide expert care and clinical leadership for the medicines optimisation agenda with regards to respiratory care in Northern Ireland. Alongside clinical practice, leadership, and service development, emphasis will be placed on monitoring and evaluating the work of the consultant respiratory pharmacist with a view to gathering the necessary evidence to support the case for further investment in such consultant pharmacist posts in the region. This short communication article outlines some of the clinical and economic factors associated with the decisions to invest in the consultant pharmacist model of care in Northern Irelandhttps://www.mdpi.com/2226-4787/9/4/177consultantrespiratorypharmacistoptimisationpharmacist servicesservice development and implementation |
| spellingShingle | Cairine Gormley Maureen Spargo Glenda Fleming Brendan Moore Michael Scott Rose Sharkey Anne Friel Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland Pharmacy consultant respiratory pharmacist optimisation pharmacist services service development and implementation |
| title | Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland |
| title_full | Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland |
| title_fullStr | Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland |
| title_full_unstemmed | Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland |
| title_short | Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland |
| title_sort | medicines optimisation for respiratory patients the establishment of a new consultant respiratory pharmacist role in northern ireland |
| topic | consultant respiratory pharmacist optimisation pharmacist services service development and implementation |
| url | https://www.mdpi.com/2226-4787/9/4/177 |
| work_keys_str_mv | AT cairinegormley medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland AT maureenspargo medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland AT glendafleming medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland AT brendanmoore medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland AT michaelscott medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland AT rosesharkey medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland AT annefriel medicinesoptimisationforrespiratorypatientstheestablishmentofanewconsultantrespiratorypharmacistroleinnorthernireland |